Clinical Trial Update: Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPD [Phase 4]

View source ↗

Summary

A Phase 4 study comparing levofloxacin and prulifloxacin in patients with acute exacerbation of COPD; the trial has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Prulifloxacin (Prulifloxacin)

Snippet

Sponsor: Fadoi Foundation, Italy | Conditions: COPD Exacerbation | Phase 4 | Status: COMPLETED | Results posted: 2025-02-11